Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether fish oil supplementation with Lovaza,
formally known as Omacor will result in a significant reduction in serum triglyceride (TG),
an increase in high density lipoproteins(HDL), and an improvement of endothelial dysfunction.